R

Active Director Director DIN 10220897
DIN 10220897 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh

Data last updated:

Rakesh is a Director at Rockherry Foundation (since 2024) and Director at Aagaz Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma.

DIN 10220897
Primary Designation Director
Industry Pharma
First Appointment 30 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rockherry Foundation U88900RJ2024NPL092244
Director20 Jan 20242024Active
Director30 Jun 20232023Active

Board colleagues of Rakesh

NameDINCompanyDesignation
Sharda10220898Rockherry Foundation , Aagaz Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rockherry Foundation
Aagaz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh

Rakesh currently holds 2 directorships: Rockherry Foundation (Director, since 20 Jan 2024); Aagaz Pharmaceuticals Private Limited (Director, since 30 Jun 2023).

Rakesh was first appointed on 30 Jun 2023 as Director at Aagaz Pharmaceuticals Private Limited. The most recent appointment on record is 20 Jan 2024 at Rockherry Foundation.

The current boards of Rakesh's companies include Sharda (Rockherry Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available